TAMMY MINSHALL: Open Payments
NPI 1851821987 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 85 payments from 20 companies in 2025. Trend: 2023 $1,553 · 2024 $1,254 · 2025 $1,455
Food & beverage: $1,455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $274 |
| PFIZER INC. | 16 | $221 |
| Amgen Inc. | 12 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $131 |
| AstraZeneca Pharmaceuticals LP | 7 | $118 |
| Axsome Therapeutics, Inc. | 5 | $109 |
| Antares Pharma, Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Lilly USA, LLC | 3 | $47 |
Products named: NURTEC ODT, CAPLYTA, VRAYLAR, OTEZLA, AIRSUPRA, XYOSTED, REXULTI, Auvelity.
Industry payments across MO — which companies pay providers there.
